Hormone Therapy, Radiation Therapy, and Steroid 17alpha-monooxygenase TAK-700 in Treating Patients With High-Risk Prostate Cancer
Condition: Prostate CancerInterventions: Drug: bicalutamide; Drug: buserelin; Drug: flutamide; Drug: goserelin acetate; Drug: leuprolide acetate; Drug: orteronel; Drug: triptorelinSponsors: Radiation Therapy Oncology Group; National Cancer Institute (NCI); NRG OncologyActive, not recruiting - verified May 2015
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Hormonal Therapy | Hormones | Prostate Cancer | Radiation Therapy | Research